β-Cell Dysfunction, Hepatic Lipid Metabolism, and Cardiovascular Health in Type 2 Diabetes: New Directions of Research and Novel Therapeutic Strategies

Cardiovascular disease (CVD) remains a major problem for people with type 2 diabetes mellitus (T2DM), and dyslipidemia is one of the main drivers for both metabolic diseases. In this review, the major pathophysiological and molecular mechanisms of β-cell dysfunction and recovery in T2DM are discusse...

Descripción completa

Detalles Bibliográficos
Autor principal: Al-Mrabeh, Ahmad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927138/
https://www.ncbi.nlm.nih.gov/pubmed/33672162
http://dx.doi.org/10.3390/biomedicines9020226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927138/
https://www.ncbi.nlm.nih.gov/pubmed/33672162
http://dx.doi.org/10.3390/biomedicines9020226

Ejemplares similares